BN Business News
Unternehmen hinzufügen →
Diese Übersetzung wird noch vorbereitet. Bis dahin zeigen wir vorübergehend die englische Originalversion.

Internationaler Handel · 6.4.20231 Min. Lesezeit

Certain Dermatological Treatment Devices and Components Thereof; Institution of Investigation

Lokale automatische Übersetzung · Originalsprache der Quelle

Zusammenfassung

Notice is hereby given that a complaint was filed with the U.S. International Trade Commission on March 1, 2023, under section 337 of the Tariff Act of 1930, as amended, on behalf of Serendia, LLC of Lake Forest, California. Supplements were filed on March 2, 13 and 14, 2023. The complaint alleges violations of section 337 based upon the importation into the United States, the sale for importation, and the sale within the United States after importation of certain dermatological treatment devices and components thereof by reason of the infringement of certain claims of U.S. Patent No. 9,480,836 ("the '836 Patent"); U.S. Patent No. 10,058,379 ("the '379 Patent"); U.S. Patent No. 11,406,444 ("the '444 Patent"); U.S. Patent No. 9,320,536 ("the '536 Patent"); U.S. Patent No. 9,775,774 ("the " '774 Patent"); and U.S. Patent No. 10,869,812 ("the '812 Patent"). The complaint further alleges that an industry in the United States exists as required by the applicable Federal Statute. The complainant requests that the Commission institute an investigation and, after the investigation, issue a limited exclusion order and cease and desist orders.

Originalsprache der Quelle: Federal Register — International Trade CommissionOriginalquelle öffnen →

Weitere Themen

Business-Analysen →